Ultragenyx Pharmaceutical Inc. SEC filings RARE

Ultragenyx Pharmaceutical Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jul 20, 2015. Its latest annual report, Form ARS, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (acquisition or sale of assets, results of operations, exit or restructuring costs). The company's fiscal year ends on December 31.

Ultragenyx Pharmaceutical Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Acquisition or sale of assets, Results of operations, Exit or restructuring costs
Nov 3, 2026 Oct 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 30, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Oct 20, 2026 —
4 Insider transaction Oct 19, 2026 Oct 15, 2026
8-K Current report
Other events
Oct 19, 2026 Oct 19, 2026
8-K Current report
Material agreement
Oct 14, 2026 Oct 8, 2026
8-K Current report
Material agreement
Oct 7, 2026 Oct 6, 2026
8-K Current report
Other events
Sep 17, 2026 Sep 17, 2026
4 Insider transaction Sep 15, 2026 Sep 15, 2026
144 Notice of proposed sale Sep 15, 2026 —
4 Insider transaction Sep 8, 2026 Sep 3, 2026
8-K Current report
Other events
Sep 2, 2026 Sep 2, 2026
8-K Current report
Other events
Aug 19, 2026 Aug 19, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2026 —
8-K Current report
Other events
Aug 11, 2026 Aug 7, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
4 Insider transaction Aug 4, 2026 Aug 3, 2026
4 Insider transaction Aug 4, 2026 Aug 3, 2026
144 Notice of proposed sale Aug 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 31, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jul 31, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 30, 2026 —
4 Insider transaction Jul 6, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 1, 2026 —
4 Insider transaction Jun 15, 2026 Jun 15, 2026
4 Insider transaction Jun 15, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
S-8 Employee stock plan registration Jun 12, 2026 —
4 Insider transaction Jun 1, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
144 Notice of proposed sale May 18, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
May 18, 2026 May 14, 2026
SCHEDULE 13G Ownership over 5% (passive) May 12, 2026 —
4 Insider transaction May 6, 2026 May 5, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
4 Insider transaction May 4, 2026 May 1, 2026
144 Notice of proposed sale May 1, 2026 —
DEFA14A Additional proxy material Apr 30, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
4 Insider transaction Apr 24, 2026 Apr 22, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
8-K Current report
Other events
Apr 2, 2026 Apr 2, 2026
144 Notice of proposed sale Apr 1, 2026 —
8-K Current report
Other events
Mar 30, 2026 Mar 30, 2026
ARS Annual report to shareholders Mar 27, 2026 Dec 31, 2025
DEFA14A Additional proxy material Mar 27, 2026 —
DEF 14A Proxy statement Mar 27, 2026 May 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
8-K Current report
Other events
Mar 12, 2026 Mar 12, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
144 Notice of proposed sale Mar 10, 2026 —
144 Notice of proposed sale Mar 6, 2026 —
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 2, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
144 Notice of proposed sale Mar 3, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
8-K Current report
Other events
Feb 23, 2026 Feb 23, 2026
10-K Annual report Feb 18, 2026 Dec 31, 2025
8-K Current report
Results of operations, Exit or restructuring costs
Feb 12, 2026 Feb 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2026 —
4 Insider transaction Feb 3, 2026 Feb 2, 2026
8-K Current report
Other events
Feb 3, 2026 Feb 3, 2026
144 Notice of proposed sale Feb 2, 2026 —
8-K Current report
Other events
Jan 30, 2026 Jan 30, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
144 Notice of proposed sale Jan 2, 2026 —
8-K Current report
Other events
Dec 30, 2025 Dec 30, 2025
4 Insider transaction Dec 30, 2025 Dec 29, 2025
8-K Current report
Other events
Dec 29, 2025 Dec 29, 2025
4 Insider transaction Dec 11, 2025 Dec 10, 2025
144 Notice of proposed sale Dec 10, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 5, 2025 —
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Material agreement, Results of operations
Nov 4, 2025 Nov 3, 2025
8-K Current report
Other events
Oct 30, 2025 Oct 30, 2025
4 Insider transaction Oct 14, 2025 Oct 13, 2025
4 Insider transaction Sep 19, 2025 Sep 18, 2025
144 Notice of proposed sale Sep 12, 2025 —
4 Insider transaction Sep 12, 2025 Sep 12, 2025
8-K Current report
Other events
Sep 8, 2025 Sep 8, 2025
4 Insider transaction Sep 8, 2025 Sep 5, 2025
8-K Current report
Other events
Aug 18, 2025 Aug 18, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
8-K Current report
Other events
Jul 31, 2025 Jul 31, 2025
S-8 Employee stock plan registration Jul 18, 2025 —
8-K Current report
Other events
Jul 11, 2025 Jul 11, 2025
8-K Current report
Other events
Jul 9, 2025 Jul 9, 2025
8-K Current report
Other events
Jun 27, 2025 Jun 27, 2025
4 Insider transaction Jun 23, 2025 Jun 20, 2025
144 Notice of proposed sale Jun 20, 2025 —
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
8-K Current report
Officer or director change, Shareholder vote results
May 19, 2025 May 15, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
4 Insider transaction May 5, 2025 Apr 21, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 24, 2025 —
ARS Annual report to shareholders Mar 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Mar 28, 2025 —
DEF 14A Proxy statement Mar 28, 2025 May 15, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 3, 2025 Feb 27, 2025
144 Notice of proposed sale Feb 28, 2025 —
144 Notice of proposed sale Feb 27, 2025 —
10-K Annual report Feb 19, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 13, 2025 Feb 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2025 —
8-K Current report
Results of operations
Jan 13, 2025 Jan 12, 2025
4 Insider transaction Dec 31, 2024 Dec 30, 2024
144 Notice of proposed sale Dec 30, 2024 —
8-K Current report
Other events
Dec 19, 2024 Dec 19, 2024
8-K Current report
Other events
Dec 19, 2024 Dec 19, 2024
4 Insider transaction Dec 11, 2024 Dec 10, 2024
4 Insider transaction Dec 11, 2024 Dec 9, 2024
144 Notice of proposed sale Dec 10, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Other events
Nov 12, 2024 Nov 9, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 5, 2024 Nov 5, 2024
4 Insider transaction Oct 11, 2024 Oct 10, 2024
8-K Current report
Other events
Oct 7, 2024 Oct 7, 2024
8-K Current report
Other events
Oct 3, 2024 Oct 3, 2024
4 Insider transaction Sep 18, 2024 Sep 16, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
144 Notice of proposed sale Sep 3, 2024 —
4 Insider transaction Aug 7, 2024 Aug 6, 2024
144 Notice of proposed sale Aug 6, 2024 —
10-Q Quarterly report Aug 2, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 1, 2024 Aug 1, 2024
8-K Current report
Other events
Jul 17, 2024 Jul 17, 2024
S-8 Employee stock plan registration Jul 12, 2024 —
4 Insider transaction Jul 3, 2024 Jul 2, 2024
144 Notice of proposed sale Jul 2, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
8-K Current report
Material agreement
Jun 17, 2024 Jun 13, 2024
424B5 Prospectus supplement Jun 14, 2024 —
4 Insider transaction Jun 12, 2024 Jun 12, 2024
424B5 Prospectus supplement Jun 12, 2024 —
144 Notice of proposed sale Jun 12, 2024 —
8-K Current report
Other events
Jun 12, 2024 Jun 12, 2024
8-K Current report
Other events
Jun 12, 2024 Jun 11, 2024
4 Insider transaction Jun 10, 2024 Jun 10, 2024
144 Notice of proposed sale Jun 10, 2024 —
UPLOAD Letter from the SEC Jun 10, 2024 —
8-K Current report
Other events
May 30, 2024 May 30, 2024
CORRESP Letter to the SEC May 17, 2024 —
4 Insider transaction May 3, 2024 May 2, 2024
10-Q Quarterly report May 3, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 2, 2024 May 2, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RARE (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Novato, CA
SEC filer status
Large accelerated filer
SEC CIK
1515673

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.